Therapeutic effect of atorvastatin on coronary heart disease complicated by hyperlipemia
Zhang Qichua
Abstract
Zhang Qichua
Abstract
Objective To investigate the efficacy of atorvastatin in treating the patients with coronary heart disease complicated by hyperlipemia.Methods The 40 patients in group A were treated with atorvastatin (10 mg/d);39 patients in guoup B were treated with simvastatin (20 mg/d),for a treatment course of eight weeks in both groups.Results The total cholesteral (TC),triglycerin (TG) decreased in both groups,and high density lipoprotein increased after 8 week's treatment.The total effective rates were 85%,58%,56% in group A and 50%,15%,50% in group B respectively.The cardiac events in group A were less than those in group B.Conclusion Atorvastatin is obviously effective in decreasing blood fat,which can prevent from cardiac events.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the efficacy of atorvastatin in treating the patients with coronary heart disease complicated by hyperlipemia.Methods The 40 patients in group A were treated with atorvastatin (10 mg/d);39 patients in guoup B were treated with simvastatin (20 mg/d),for a treatment course of eight weeks in both groups.Results The total cholesteral (TC),triglycerin (TG) decreased in both groups,and high density lipoprotein increased after 8 week's treatment.The total effective rates were 85%,58%,56% in group A and 50%,15%,50% in group B respectively.The cardiac events in group A were less than those in group B.Conclusion Atorvastatin is obviously effective in decreasing blood fat,which can prevent from cardiac events.
Key concepts: Atorvastatin, Medicine, Simvastatin, Coronary heart disease, Internal medicine, Group B, Cardiology, Blood lipids